glutathione and hepatitis b surface antigen hijacks TANK-binding kinase 1 to suppress type I interferon induce early autophagy Week 2, August 2024: Hepatitis

An anti-PCSK9 vaccine called AT04A consists of homologous mouse and mature human PCSK9 protein N-terminal epitope peptides from amino acid residues 153692, which is able to reduce plasma lipid levels and hinder the development of atherosclerosis

Lancet 395, 507513

The nano-missiles could deliver two drugs in response to increased ROS levels in AD lesions, subsequently diminishing A plaques, restoring neuronal function, and selectively inhibiting the NF-B pathway, thereby down-regulating the expression of pro-inflammatory factors such as IL-1 and NF-B, thus offering an effective approach for combating AD through anti-neuroinflammation and neuroprotection

Product name: BPC-157